company background image
300511 logo

Shanghai Xuerong BiotechnologyLtd SZSE:300511 Stock Report

Last Price

CN¥2.68

Market Cap

CN¥1.3b

7D

-18.5%

1Y

-63.7%

Updated

17 Jun, 2024

Data

Company Financials

Shanghai Xuerong Biotechnology Co.,Ltd.

SZSE:300511 Stock Report

Market Cap: CN¥1.3b

300511 Stock Overview

Engages in the research and development, industrial planting, and sale of fresh edible mushrooms in the People’s Republic of China.

300511 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Shanghai Xuerong Biotechnology Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shanghai Xuerong BiotechnologyLtd
Historical stock prices
Current Share PriceCN¥2.68
52 Week HighCN¥7.99
52 Week LowCN¥2.58
Beta0.13
1 Month Change-32.66%
3 Month Change-35.27%
1 Year Change-63.73%
3 Year Change-66.50%
5 Year Change-67.67%
Change since IPO-68.46%

Recent News & Updates

There's No Escaping Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Muted Revenues Despite A 25% Share Price Rise

May 13
There's No Escaping Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Muted Revenues Despite A 25% Share Price Rise

Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Shares Bounce 25% But Its Business Still Trails The Industry

Mar 15
Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Shares Bounce 25% But Its Business Still Trails The Industry

Recent updates

There's No Escaping Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Muted Revenues Despite A 25% Share Price Rise

May 13
There's No Escaping Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Muted Revenues Despite A 25% Share Price Rise

Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Shares Bounce 25% But Its Business Still Trails The Industry

Mar 15
Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Shares Bounce 25% But Its Business Still Trails The Industry

Shareholder Returns

300511CN FoodCN Market
7D-18.5%-1.5%0.06%
1Y-63.7%-17.0%-16.1%

Return vs Industry: 300511 underperformed the CN Food industry which returned -17% over the past year.

Return vs Market: 300511 underperformed the CN Market which returned -16.1% over the past year.

Price Volatility

Is 300511's price volatile compared to industry and market?
300511 volatility
300511 Average Weekly Movement10.6%
Food Industry Average Movement5.8%
Market Average Movement6.8%
10% most volatile stocks in CN Market10.2%
10% least volatile stocks in CN Market4.2%

Stable Share Price: 300511's share price has been volatile over the past 3 months.

Volatility Over Time: 300511's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
19972,513Yongping Yangwww.xuerong.com

Shanghai Xuerong Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research and development, industrial planting, and sale of fresh edible mushrooms in the People’s Republic of China. It offers shiitake, shiji, king oyster, velvet, antler, and shiitake mushrooms, as well as Pleurotus eryngii and Flammulina velutipes. The company was formerly known as Shanghai Gaorong Food Co., Ltd.

Shanghai Xuerong Biotechnology Co.,Ltd. Fundamentals Summary

How do Shanghai Xuerong BiotechnologyLtd's earnings and revenue compare to its market cap?
300511 fundamental statistics
Market capCN¥1.34b
Earnings (TTM)-CN¥405.53m
Revenue (TTM)CN¥2.33b

0.6x

P/S Ratio

-3.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300511 income statement (TTM)
RevenueCN¥2.33b
Cost of RevenueCN¥2.41b
Gross Profit-CN¥85.37m
Other ExpensesCN¥320.16m
Earnings-CN¥405.53m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.81
Gross Margin-3.67%
Net Profit Margin-17.43%
Debt/Equity Ratio191.9%

How did 300511 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.